GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Greenyn Biotechnology Co Ltd (ROCO:6846) » Definitions » Other Stockholders Equity

Greenyn Biotechnology Co (ROCO:6846) Other Stockholders Equity : NT$65.0 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Greenyn Biotechnology Co Other Stockholders Equity?

Greenyn Biotechnology Co's Other Stockholders Equity for the quarter that ended in Mar. 2024 was NT$65.0 Mil.

Greenyn Biotechnology Co's quarterly Other Stockholders Equity increased from Sep. 2023 (NT$52.0 Mil) to Dec. 2023 (NT$52.0 Mil) and increased from Dec. 2023 (NT$52.0 Mil) to Mar. 2024 (NT$65.0 Mil).

Greenyn Biotechnology Co's annual Other Stockholders Equity increased from Dec. 2021 (NT$24.0 Mil) to Dec. 2022 (NT$37.3 Mil) and increased from Dec. 2022 (NT$37.3 Mil) to Dec. 2023 (NT$52.0 Mil).


Greenyn Biotechnology Co Other Stockholders Equity Historical Data

The historical data trend for Greenyn Biotechnology Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenyn Biotechnology Co Other Stockholders Equity Chart

Greenyn Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
- 21.55 24.02 37.29 51.97

Greenyn Biotechnology Co Quarterly Data
Dec19 Jun20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.97 51.97 51.97 51.97 65.03

Greenyn Biotechnology Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Greenyn Biotechnology Co Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Greenyn Biotechnology Co's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Greenyn Biotechnology Co (ROCO:6846) Business Description

Traded in Other Exchanges
N/A
Address
5th Floor, No 43 Keya Road, Daya District, Taichung, TWN
Greenyn Biotechnology Co Ltd has developed Insumate patented sequenced peptide, Antromax Antrodia cinnamomea mycelia, and Zymologist fermented liquid.

Greenyn Biotechnology Co (ROCO:6846) Headlines

No Headlines